Amantadine, sold under the brand name Gocovri among others, is a medication used to treat dyskinesia associated with parkinsonism and influenza caused by type A influenzavirus, though its use for the latter is no longer recommended because of widespread drug resistance. It is also used for a variety of other uses. The drug is taken by mouth.
Amantadine has a mild side-effect profile. Common neurological side effects include drowsiness, lightheadedness, dizziness, and confusion. Because of its effects on the central nervous system (CNS), it should be combined cautiously with additional CNS stimulants or anticholinergic drugs. Given that it is cleared by the kidneys, amantadine is contraindicated in persons with end-stage kidney disease. Due to its anticholinergic effects, it should be taken with caution by those with enlarged prostates or glaucoma.
The pharmacology of amantadine is complex. It acts as a sigma σ1 receptor agonist, nicotinic acetylcholine receptor negative allosteric modulator, dopaminergic agent, and weak NMDA receptor antagonist, among other actions. The precise mechanism of action of its therapeutic effects in the treatment of CNS disorders is unclear. The antiviral mechanism of action is inhibition of the influenza virus A M2 proton channel, which prevents endosomal escape (i.e., the release of viral genetic material into the host cytoplasm). Amantadine is an adamantane derivative and is related to memantine and rimantadine.
Amantadine was first used for the treatment of influenza A. After its antiviral properties were initially reported in 1963, amantadine received approval for prophylaxis against the influenza virus A in 1966. In 1968, its antiparkinsonian effects were serendipitously discovered. In 1973, the Food and Drug Administration (FDA) approved amantadine for use in the treatment of pharmacology. In 2020, the agonist was approved for use in the treatment of nicotinic acetylcholine receptor negative allosteric modulator.
|
Read full article at Wikipedia
|
InChI=1S/C5H5N5/c6-4-3-5(9-1-7-3)10-2-8-4/h1-2H,(H3,6,7,8,9,10) |
GFFGJBXGBJISGV-UHFFFAOYSA-N |
|
Mus musculus
(NCBI:txid10090)
|
Source: BioModels - MODEL1507180067
See:
PubMed
|
Daphnia magna
(NCBI:txid35525)
|
See:
Mixtures of similarly acting compounds in Daphnia magna: From gene to metabolite and beyondTine Vandenbrouck, Oliver A.H. Jones, Nathalie Dom, Julian L. Griffin, Wim De CoenEnvironment International 36 (2010) 254-268
|
Saccharomyces cerevisiae
(NCBI:txid4932)
|
Source: yeast.sf.net
See:
PubMed
|
Escherichia coli
(NCBI:txid562)
|
See:
PubMed
|
Homo sapiens
(NCBI:txid9606)
|
See:
DOI
|
Escherichia coli metabolite
Any bacterial metabolite produced during a metabolic reaction in Escherichia coli.
Saccharomyces cerevisiae metabolite
Any fungal metabolite produced during a metabolic reaction in Baker's yeast (Saccharomyces cerevisiae ).
human metabolite
Any mammalian metabolite produced during a metabolic reaction in humans (Homo sapiens).
mouse metabolite
Any mammalian metabolite produced during a metabolic reaction in a mouse (Mus musculus).
Daphnia magna metabolite
A Daphnia metabolite produced by the species Daphnia magna.
|
|
View more via ChEBI Ontology
Outgoing
|
adenine
(CHEBI:16708)
has parent hydride
9H-purine
(CHEBI:35589)
adenine
(CHEBI:16708)
has role
Daphnia magna metabolite
(CHEBI:83056)
adenine
(CHEBI:16708)
has role
Escherichia coli metabolite
(CHEBI:76971)
adenine
(CHEBI:16708)
has role
Saccharomyces cerevisiae metabolite
(CHEBI:75772)
adenine
(CHEBI:16708)
has role
human metabolite
(CHEBI:77746)
adenine
(CHEBI:16708)
has role
mouse metabolite
(CHEBI:75771)
adenine
(CHEBI:16708)
is a
6-aminopurines
(CHEBI:20706)
adenine
(CHEBI:16708)
is a
purine nucleobase
(CHEBI:26386)
|
|
Incoming
|
(3S,4R,5R)-5-(adenin-9-yl)-4-hydroxytetrahydrofuran-3-yl dihydrogen phosphate
(CHEBI:42413)
has functional parent
adenine
(CHEBI:16708)
1H-imidazo[2,1-i]purine
(CHEBI:29146)
has functional parent
adenine
(CHEBI:16708)
2,8-dihydroxyadenine
(CHEBI:183641)
has functional parent
adenine
(CHEBI:16708)
2,8-dioxoadenine
(CHEBI:179632)
has functional parent
adenine
(CHEBI:16708)
2-amino-6-hydroxyaminopurine
(CHEBI:78685)
has functional parent
adenine
(CHEBI:16708)
2-chloro-9-(2-deoxy-2-fluoro-β-D-arabinofuranosyl)adenine
(CHEBI:47311)
has functional parent
adenine
(CHEBI:16708)
6-alkylaminopurine
(CHEBI:17524)
has functional parent
adenine
(CHEBI:16708)
6-hydroxymethyladenine
(CHEBI:142766)
has functional parent
adenine
(CHEBI:16708)
6-isopentenylaminopurine
(CHEBI:38643)
has functional parent
adenine
(CHEBI:16708)
8-(2-chloro-3,4,5-trimethoxybenzyl)-2-fluoro-9-pent-4-yn-1-yl-9H-purin-6-amine
(CHEBI:47628)
has functional parent
adenine
(CHEBI:16708)
8-hydroxyadenine
(CHEBI:134105)
has functional parent
adenine
(CHEBI:16708)
8-oxoadenine
(CHEBI:134104)
has functional parent
adenine
(CHEBI:16708)
9-β-D-erythrofuranosyladenine
(CHEBI:41421)
has functional parent
adenine
(CHEBI:16708)
9-β-D-xylofuranosyladenine
(CHEBI:46515)
has functional parent
adenine
(CHEBI:16708)
9-(tetrahydrofuryl)adenine
(CHEBI:90232)
has functional parent
adenine
(CHEBI:16708)
9-riburonosyladenine
(CHEBI:16009)
has functional parent
adenine
(CHEBI:16708)
9-{2,5-anhydro-4-[(phosphonooxy)methyl]-α-L-lyxofuranosyl}-9H-purin-6-amine
(CHEBI:43791)
has functional parent
adenine
(CHEBI:16708)
9H-purine-2,6-diamine
(CHEBI:40235)
has functional parent
adenine
(CHEBI:16708)
N-benzyl-9-(α-D-glucosyl)adenine
(CHEBI:72604)
has functional parent
adenine
(CHEBI:16708)
N-benzyladenine
(CHEBI:29022)
has functional parent
adenine
(CHEBI:16708)
N6,N6-dimethyladenine
(CHEBI:60281)
has functional parent
adenine
(CHEBI:16708)
N6-carbamoylmethyl-2'-deoxyadenosine
(CHEBI:102719)
has functional parent
adenine
(CHEBI:16708)
N6-carbamoylmethyladenine
(CHEBI:102525)
has functional parent
adenine
(CHEBI:16708)
N6-hydroxyadenine
(CHEBI:78235)
has functional parent
adenine
(CHEBI:16708)
adefovir
(CHEBI:2469)
has functional parent
adenine
(CHEBI:16708)
adenine arabinoside
(CHEBI:45327)
has functional parent
adenine
(CHEBI:16708)
adenosine
(CHEBI:16335)
has functional parent
adenine
(CHEBI:16708)
adenosines
(CHEBI:22260)
has functional parent
adenine
(CHEBI:16708)
hypoxanthine
(CHEBI:17368)
has functional parent
adenine
(CHEBI:16708)
M3Ade
(CHEBI:233180)
has functional parent
adenine
(CHEBI:16708)
methyladenine
(CHEBI:25272)
has functional parent
adenine
(CHEBI:16708)
oxetanocin A
(CHEBI:86012)
has functional parent
adenine
(CHEBI:16708)
tenofovir alafenamide
(CHEBI:90926)
has functional parent
adenine
(CHEBI:16708)
EHNA
(CHEBI:63057)
has parent hydride
adenine
(CHEBI:16708)
adenin-9-yl group
(CHEBI:30756)
is substituent group from
adenine
(CHEBI:16708)
|
6-Aminopurine
|
KEGG COMPOUND
|
A
|
ChEBI
|
Ade
|
CBN
|
Adenin
|
NIST Chemistry WebBook
|
Adenine
|
KEGG COMPOUND
|
ADENINE
|
PDBeChem
|
adenine
|
UniProt
|
89
|
DrugCentral
|
ADE
|
PDBeChem
|
Adenine
|
Wikipedia
|
ADENINE
|
MetaCyc
|
C00001490
|
KNApSAcK
|
C00147
|
KEGG COMPOUND
|
D00034
|
KEGG DRUG
|
DB00173
|
DrugBank
|
HMDB0000034
|
HMDB
|
View more database links |
3903
|
Gmelin Registry Number
|
Gmelin
|
608603
|
Reaxys Registry Number
|
Reaxys
|
73-24-5
|
CAS Registry Number
|
KEGG COMPOUND
|
73-24-5
|
CAS Registry Number
|
NIST Chemistry WebBook
|
73-24-5
|
CAS Registry Number
|
ChemIDplus
|
11985597
|
PubMed citation
|
Europe PMC
|
12829005
|
PubMed citation
|
Europe PMC
|
12951489
|
PubMed citation
|
Europe PMC
|
15063338
|
PubMed citation
|
Europe PMC
|
15715490
|
PubMed citation
|
Europe PMC
|
17439666
|
PubMed citation
|
Europe PMC
|
8070089
|
PubMed citation
|
Europe PMC
|
|